Reports
Search reports, investigative results, and agency plansShowing 11 - 20 of 201 results
U.S. Agency for International Development OIG
COVID-19: Audit of Costs Incurred by Chemonics International from March 1, 2020, to March 31, 2022
U.S. Agency for International Development OIG
COVID-19 Audit of Costs Incurred by Save The Children, March 1, 2020 to March 31, 2022
U.S. Agency for International Development OIG
COVID-19: Audit of Costs Incurred by JSI Research & Training. from March 1, 2020 to March 31, 2022
U.S. Agency for International Development OIG
COVID-19: Audit of Costs Incurred by Right to Care from March 1, 2020, to March 31, 2022
U.S. Agency for International Development OIG
COVID-19: Audit of Costs Incurred by International Rescue Committee from March 1, 2020, to March 31, 2022
U.S. Agency for International Development OIG
COVID-19: Audit of Costs Incurred by CARE USA from March 1, 2020 to March 31, 2022
U.S. Agency for International Development OIG
COVID-19: Audit of Costs Incurred by Jhpiego Corporation from March 1, 2020 to March 31, 2022
U.S. Agency for International Development OIG
COVID-19: Audit of Costs Incurred by FHI-360 from March 1, 2020 to March 31, 2022
Department of Veterans Affairs OIG
Comprehensive Healthcare Inspection Summary Report: Evaluation of Breast Cancer Surveillance in Veterans Health Administration Facilities
This Office of Inspector General (OIG) Comprehensive Healthcare Inspection Program report evaluates notification and surveillance for patients with mammogram results requiring action during the COVID-19 pandemic. The inspections involved interviews with key staff and evaluations of clinical processes. The OIG reviewed providers’ notification of mammogram results requiring action to patients within VHA’s defined time frame and patients’ completion of the recommended actions. The OIG issued no recommendations for improvement.
Department of the Treasury OIG
Desk Review of the State of Utah
The objective of this desk review is to evaluate the State of Utah's documentation supporting the uses of its Coronavirus Relief Fund proceeds as reported in GrantSolutions, and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data as reported in the GrantSolutions portal.